Globus Medical Inc’s recently made public that its COO, CFO Pfeil Keith W unloaded Company’s shares for reported $1.25 million on Jan 10 ’25. In the deal valued at $88.29 per share,14,167 shares were sold. As a result of this transaction, Pfeil Keith W now holds 0 shares worth roughly $ 0.0.
Then, Pfeil Keith W bought 14,167 shares, generating $1,250,772 in total proceeds.
Before that, Huller Kelly sold 2,500 shares. Globus Medical Inc shares valued at $217,502 were divested by the SVP, GC, Corporate Secretary at a price of $87.00 per share. As a result of the transaction, Huller Kelly now holds 0 shares, worth roughly $0.0.
BofA Securities upgraded its Globus Medical Inc [GMED] rating to a Neutral from a an Underperform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in early December from “an Equal-weight” to “an Overweight”. Wells Fargo also remained covering GMED and has increased its forecast on August 07, 2024 with a “an Overweight” recommendation from previously “an Equal weight” rating. Piper Sandler revised its rating on May 20, 2024. It rated GMED as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of GMED
On Tuesday, Globus Medical Inc [NYSE:GMED] saw its stock jump 1.07% to $84.83. Over the last five days, the stock has lost -2.92%. Globus Medical Inc shares have risen nearly 2.56% since the year began. Nevertheless, the stocks have risen 60.82% over the past one year. While a 52-week high of $94.93 was reached on 01/30/25, a 52-week low of $49.33 was recorded on 01/02/25. SMA at 50 days reached $86.50, while 200 days put it at $74.71.
Levels Of Support And Resistance For GMED Stock
The 24-hour chart illustrates a support level at 83.78, which if violated will result in even more drops to 82.72. On the upside, there is a resistance level at 85.44. A further resistance level may holdings at 86.04. The Relative Strength Index (RSI) on the 14-day chart is 37.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.16%. Stochastics %K at 9.78% indicates the stock is a buying.
